The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMXC.L Regulatory News (MXC)

  • There is currently no data for MXC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second Price Monitoring Extn

17 Feb 2021 16:41

RNS Number : 4849P
MGC Pharmaceuticals Limited
17 February 2021
 

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APMGPUUCPUPGGQM

Date   Source Headline
2nd Sep 20219:05 amRNSSecond Price Monitoring Extn
2nd Sep 20219:00 amRNSPrice Monitoring Extension
2nd Sep 20217:00 amRNSCimetrA import approval granted in India
1st Sep 20217:00 amRNSPreliminary Financial Report for 30 June 2021
31st Aug 20217:00 amRNSProposed Issue of Securities and Appendix 3B
27th Aug 20219:00 amRNSHolder Update - MXCOE Listed Options
26th Aug 20219:05 amRNSSecond Price Monitoring Extn
26th Aug 20219:00 amRNSPrice Monitoring Extension
26th Aug 20217:10 amRNSMGC Pharma executes US$24m agreement with US firm
12th Aug 20211:21 pmRNSResults of General Meeting
6th Aug 20218:47 amRNSGeneral Meeting Information and Webinar
3rd Aug 20217:00 amRNSExpiry of Share Options
26th Jul 20217:00 amRNSQuarterly Results
16th Jul 20217:56 amRNSAmendment to Expiry of Share Options
15th Jul 20217:17 amRNSCannabinoid Patent Application Submitted
13th Jul 202110:52 amRNSExpiry of Share Options
13th Jul 20219:38 amRNSIssue of Shares and Cleansing Statement
12th Jul 20217:00 amRNSPhase III CimetrA™ Clinical Trial Commences
9th Jul 20219:16 amRNSCleansing Notice and Appendix 2A
9th Jul 20217:00 amRNSNotice of GM
15th Jun 20217:00 amRNSCannEpil - Primary Care Reimbursement in Ireland
9th Jun 20217:24 amRNSAppointment of Company Secretary
25th May 20217:00 amRNS2021 Clinical Trials Program Update
17th May 20217:58 amRNSCimetrA Patent Submitted to European IP Office
14th May 20217:59 amRNSAppendix 3G
14th May 20217:50 amRNSAppendix 2A - Issue of Shares
7th May 20217:27 amRNSResearch Update - ArtemiC
6th May 20212:00 pmRNSPrice Monitoring Extension
6th May 20217:31 amRNSASX Trading Halt
4th May 20217:00 amRNSNew ArtemiC Order Received From Swiss PharmaCan AG
28th Apr 20217:00 amRNSApplication to Health Canada for ArtemiC Approval
27th Apr 20217:00 amRNSQuarterly Results
22nd Apr 20217:00 amRNSAcquisition of MediCaNL
21st Apr 202112:36 pmRNSIssue of Equity
9th Apr 20217:00 amRNSInvestor Presentation
8th Apr 202111:00 amRNSCorporate Update
7th Apr 20217:08 amRNSArtemiC Rescue First Delivery and March Revenue
31st Mar 202112:54 pmRNSGM Statement
24th Mar 20219:03 amRNSAppendix 2A - Issue of Shares
22nd Mar 20217:30 amRNSPhase III Clinical Trial of CimetrA Approved
19th Mar 20217:00 amRNSNotice of GM
9th Mar 20218:19 amRNSAppendix 2A - Issue of Shares
9th Mar 20217:00 amRNSDirector/PDMR Shareholding
2nd Mar 20217:00 amRNSIncreased initial supply agreement for ArtemiC
26th Feb 20217:17 amRNSNotice of GM
26th Feb 20217:00 amRNSHalf-year Report
25th Feb 20219:05 amRNSSecond Price Monitoring Extn
25th Feb 20219:00 amRNSPrice Monitoring Extension
19th Feb 20214:41 pmRNSSecond Price Monitoring Extn
19th Feb 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.